Oslo, 26 May 2023 - Observe Medical ASA (the "Company" or "Observe Medical") has
received initial orders from distributors for delivery of UnoMeterT products and
is expecting to ship the first units to customers in June.

The total value of these initial orders is NOK 8.2 million. The distributors
that have signed the orders have historically had annual repetitive purchases of
around NOK 50 million. Dialogues with these and other distributors continue to
advance, and with products expected to be on the market relatively soon, Observe
Medical is expecting additional orders to be confirmed.

"Our dialogue with distributors and these initial orders confirms strong demand
for high-quality urine measurement products. We are pleased to have established
an efficient and reliable supply chain for delivery of the products to
distributors and ultimately to their healthcare customers," said Observe Medical
CEO, Rune Nystad.

In parallel, Observe Medical continues the process with Convatec to conclude the
contemplated acquisition of the UnoMeterT and Abdo-PressureT products, which was
announced in October 2022. The delivery of the products described herein is
conditional upon the agreement with Convatec being entered into and that Observe
Medical secures the required financing to execute and complete the contemplated
agreement with Convatec and to roll-out the products. The agreement with
Convatec is expected to be signed relatively soon, but no assurance can at this
stage be given that this agreement will be signed and that the other conditions
for the roll-out of the products will be fulfilled nor the timing thereof.

The attached Company presentation provides more background and details on the
above mentioned initial orders, the conditions for the ability to reach the
targets set out therein, the process with Convatec and preliminary projections
of future sales.

For further information, please contact:


Rune Nystad, CEO Observe Medical
Mobile: +47 916 24 683
E-mail: rune.nystad@observemedical.com

Per Arne Nygård, CFO of Observe Medical
Mobile: +47 411 04 345
E-mail: perarne.nygard@observemedical.com

About Observe Medical


Observe Medical is a Nordic medtech company that develops, markets and sells
innovative medtech products for the global market. The Company is committed
to improving patient welfare and patient outcomes, improving clinical data
accuracy and promoting positive health economics.

The Company seeks to drive growth by leveraging its expertise in sales
and commercialization of its broad portfolio of medical technology products,
mainly

in urine measurement, ultrasound, anesthesiology/ICUs, surgery and wound
care, in combination with targeted M&A.

The Company is headquartered in Oslo, Norway, with additional offices in
Narvik, Norway and Gothenburg, Sweden, and subsidiaries in Finland and the US.
In

addition, Observe Medical has a direct sale organization in the Nordics and
a distributor network internationally.

Further information is available at www.observemedical.com.

This information is required to be disclosed in accordance with the EU
Market Abuse Regulation. The information was submitted for publication by CFO
Per Arne Nygård at 08:00 CET, 26 May 2023.